We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ROST:NASDAQRoss Stores, Inc. Analysis

Data as of 2026-09-02 - not real-time

$229.24

Latest Price

3/10Risk

Risk Level: Low

Executive Summary

At $229.24, Ross Stores, Inc. shows a bullish moving-average alignment, with shorter averages sitting above longer ones. Over a rolling month the price has lost 2.8%. With RSI at 39.6 the momentum picture is approaching oversold, alongside a bearish MACD signal. Price has been bracketed by support at $224.50 and resistance at $256.45.
The shares look overvalued at 27.6 times earnings, though no sector average was available for comparison. Analyst price targets sit 17.8% above the current price. Revenue is growing at 13.3% on a 10.8% profit margin. The 0.78% dividend yield looks covered by current payout levels.
Risk scores 3 out of 10, which is low for this asset class. With 30-day volatility of 28.2%, a beta of 0.61 and a maximum drawdown of 13.0%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
The horizons diverge: buy near-term but hold on a long view, at 3/10 conviction over the longer horizon.

Top Market Events

Updated Aug 6, 2026 0 DUBLIN, Calif., Aug. 6, 2026 /PRNewswire/ -- Ross Stores, Inc. Nasdaq: ROST plans to release its...Have you been paying attention to shares of Ross Stores ROST ?Put traders are targeting Ross Stores ROST ahead of today's earnings report

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 4/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 211.56
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 3/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 211.56
  • Analyst targets imply +17.8% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 3/10

Key Factors

  • Analyst targets imply +17.8% versus the current price
  • Revenue growth of +13.3%
  • P/E ratio of 27.6

Key Metrics & Analysis

Financial Health

Revenue Growth13.30%
Profit Margin10.85%
P/E Ratio27.6
ROE42.63%
ROA13.82%
Debt/Equity70.28
P/B Ratio10.8
Op. Cash Flow$3.7B
Free Cash Flow$2.2B

Technical Analysis

TrendBullish
RSI39.6
Support$224.50
Resistance$256.45
MA 20$240.88
MA 50$234.10
MA 200$211.56
MACDBearish
VolumeIncreasing
Fear & Greed Index91.93

Valuation

Fair Value$147.04
Target Price$269.94
Upside/Downside17.76%
GradeOvervalued
TypeGrowth
Dividend Yield0.78%

Risk Assessment

Beta0.61
Volatility28.22%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.